Protein Chip Market Benefitting from COVID-19 Outbreak and Cancer Prevalence
The outbreak of COVID-19 has highlighted the importance of diagnostics in containing the pandemic, leading to a surge in demand for functional analysis methods. This has made functional analysis a lucrative area of growth as researchers focus on identifying protein-virus interactions through various testing methods.Cancer, on the other hand, remains a key cause of shortened life expectancy globally. According to the World Health Organization (WHO), there were over 19 million new cancer cases and approximately 10 million cancer-related deaths in 2020. The critical role of protein chips in efficient cancer diagnosis, allowing fast and easy diagnostics with parallel tracking of various protein interactions, targets, small molecules, substrates of protein kinases, and protein-phospholipid interactions, will drive market demand. The broad application scope of protein chips in molecular biology and biochemistry, along with the growing sector of personalized medicine, further enhances their significance in the healthcare industry.
Proteomics Emerges as the Leading Application for Protein Chips
As of 2019, proteomics stood as the leading application area for protein chips, and it is expected to maintain this position in the coming years. Its wide usage in biomedical research and drug discovery is anticipated to be a major revenue generator for the market. Proteomics is deployed in various techniques, including superficial fluid chromatography, chromatography, x-ray crystallography, protein fractionation, spectroscopy, surface plasmon resonance, and electrophoresis. Its ability to offer accurate analysis of in-vivo outcomes makes it an essential tool in the study of tumour resistance mechanisms, disease pathogenesis, and therapeutic developments.North America and Europe to Lead the Global Protein Chip Market
North America is expected to maintain its dominance in the global protein chip market from 2021 to 2026. Well-established biotech companies in the region are projected to invest significantly in research and development of innovative technologies. Europe is also expected to show positive growth due to the rising incidence of cancer and COVID-19, prompting swift action. Analysts anticipate that Asia Pacific will closely follow this development, with protein chip adoption for diagnostics presenting lucrative opportunities in the region.Key Players in the Global Protein Chip Market
The competitive landscape of the global protein chip market is shaped by leading players such as Sigma Aldrich Corporation, Affymetrix, Inc., Biacore, SEQUENOM, Inc., Illumina, Inc., Agilent Technologies, HTS Biosystems, EMD Millipore, Life Technologies Corporation, Lumicyte, and Ciphergen Biosystems.Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ArrayIT Corporation
- PerkinElmer, Inc.
- Thermo Fischer Scientific
- Lumicyte
- Bio-Rad Laboratories
- Illumina, Inc.
- Ciphergen Biosystems
- Agilent Technologies
Methodology
LOADING...